198 related articles for article (PubMed ID: 19597130)
1. Right brain: my first tPA.
Robbins MS
Neurology; 2009 Jul; 73(2):e9-e10. PubMed ID: 19597130
[No Abstract] [Full Text] [Related]
2. [Thrombolytic therapy with tPA for the treatment of acute stroke. The Standard Treatment with Alteplase to Reverse Stroke study].
Di Pasquale G
Ital Heart J Suppl; 2000 Jul; 1(7):947-8. PubMed ID: 10935744
[No Abstract] [Full Text] [Related]
3. Tissue plasminogen activator use in a patient with acute ischemic stroke coexisting with meningioma.
Hsieh HC; Chen CH
Clin Neurol Neurosurg; 2009 Jul; 111(6):562-3. PubMed ID: 19200644
[No Abstract] [Full Text] [Related]
4. [Treatment of acute ischemic apoplexy].
Andersen G; Krieger DW; Iversen HK
Ugeskr Laeger; 2009 Mar; 171(13):1094. PubMed ID: 19321089
[No Abstract] [Full Text] [Related]
5. Thrombolytic therapy with alteplase for ischaemic stroke.
Drug Ther Bull; 2009 Feb; 47(2):14-8. PubMed ID: 19193701
[TBL] [Abstract][Full Text] [Related]
6. Tissue plasminogen activator for acute ischemic stroke: a New York city emergency medicine perspective.
Chan YF; Kwiatkowski TG; Rella JG; Rennie WP; Kwon RK; Silverman RA
J Emerg Med; 2005 Nov; 29(4):405-8. PubMed ID: 16243196
[TBL] [Abstract][Full Text] [Related]
7. The smoking-thrombolysis paradox and acute ischemic stroke.
Fisher M
Neurology; 2006 Feb; 66(3):458; author reply 458. PubMed ID: 16476964
[No Abstract] [Full Text] [Related]
8. Clinical applicability and the perfusion-diffusion mismatch theory: not yet a perfect match.
Harrer JU
Neurology; 2010 Sep; 75(12):1034-5. PubMed ID: 20739642
[No Abstract] [Full Text] [Related]
9. Tissue plasminogen activator for acute ischemic stroke.
Caplan LR
N Engl J Med; 1999 Oct; 341(16):1240-1. PubMed ID: 10523162
[No Abstract] [Full Text] [Related]
10. Influence of the stroke code activation source on the outcome of acute ischemic stroke patients.
Whitcomb DS
Neurology; 2009 May; 72(19):1709; author reply 1710. PubMed ID: 19433750
[No Abstract] [Full Text] [Related]
11. Questions about authorisation of alteplase for ischaemic stroke.
Shinton R
Lancet; 2014 Aug; 384(9944):659-60. PubMed ID: 25152265
[No Abstract] [Full Text] [Related]
12. [Possible thrombolytic treatment of cerebral ischemia of over 3 hours after the first symptom].
Cztonkowska A; Kobayashi A
Neurol Neurochir Pol; 2009; 43(4):400. PubMed ID: 19795553
[No Abstract] [Full Text] [Related]
13. Review of tissue plasminogen activator, ischemic stroke, and potential legal issues.
Liang BA; Lew R; Zivin JA
Arch Neurol; 2008 Nov; 65(11):1429-33. PubMed ID: 19001160
[TBL] [Abstract][Full Text] [Related]
14. Tissue plasminogen activator (tPA) for acute ischaemic stroke: why so much has been made of so little.
Hoffman JR
Med J Aust; 2003 Oct; 179(7):333-4. PubMed ID: 14503891
[No Abstract] [Full Text] [Related]
15. Swift or sure?: The acceptable rate of neurovascular mimics among IV tPA-treated patients.
Saver JL; Barsan WG
Neurology; 2010 Apr; 74(17):1336-7. PubMed ID: 20335563
[No Abstract] [Full Text] [Related]
16. Evidence and doubt in the translation of research into care.
Lancet; 2014 Aug; 384(9944):638. PubMed ID: 25152260
[No Abstract] [Full Text] [Related]
17. Litigation regarding tPA and stroke.
Pilcher CA
Ann Emerg Med; 2009 Mar; 53(3):404; author reply 404-5. PubMed ID: 19231673
[No Abstract] [Full Text] [Related]
18. Rapid EEG changes indicate reperfusion after tissue plasminogen activator injection in acute ischaemic stroke.
Finnigan SP; Rose SE; Chalk JB
Clin Neurophysiol; 2006 Oct; 117(10):2338-9. PubMed ID: 16926108
[No Abstract] [Full Text] [Related]
19. Using tPA for acute stroke in a rural setting.
Gross H; Hall C; Switzer JA; Adams RJ; Wang S; Hess DC; Nichols FT; Pardue C
Neurology; 2007 May; 68(22):1957-8; author reply 1958. PubMed ID: 17536059
[No Abstract] [Full Text] [Related]
20. Acute ischemic stroke: Not a moment to lose.
Miller J; Mink J
Nursing; 2009 May; 39(5):37-42; quiz 42-3. PubMed ID: 19395934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
